Filippinerne - engelsk - FDA (Food And Drug Administration)

zydus philippines, inc.; distributor: zydus philippines, inc. - aripiprazole - tablet - 15 mg

Filippinerne - engelsk - FDA (Food And Drug Administration)

zydus philippines, inc.; distributor: zydus philippines, inc. - aripiprazole - tablet - 5mg

USA - engelsk - NLM (National Library of Medicine)

zydus lifesciences limited - felbamate (unii: x72rbb02n8) (felbamate - unii:x72rbb02n8) - felbamate 400 mg - felbamate tablets, usp are not indicated as a first line antiepileptic treatment (see warnings ). felbamate tablets, usp are recommended for use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use. if these criteria are met and the patient has been fully advised of the risk, and has provided written acknowledgement, felbamate can be considered for either monotherapy or adjunctive therapy in the treatment of partial seizures, with and without generalization, in adults with epilepsy and as adjunctive therapy in the treatment of partial and generalized seizures associated with lennox-gastaut syndrome in children. felbamate is contraindicated in patients with known hypersensitivity to felbamate, its ingredients, or known sensitivity to other carbamates. it should not be used in patients with a history of any blood dyscrasia or hepa

USA - engelsk - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - etodolac (unii: 2m36281008) (etodolac - unii:2m36281008) - etodolac 400 mg - carefully consider the potential benefits and risks of etodolac extended-release tablets and other treatment options before deciding to use etodolac extended-release tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). etodolac extended-release tablets are indicated: *    for relief of signs and symptoms of juvenile arthritis *    for relief of the signs and symptoms of rheumatoid arthritis *    for relief of the signs and symptoms of osteoarthritis etodolac extended-release tablets are contraindicated in patients with known hypersensitivity to etodolac. etodolac extended-release tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions   and precautions, preexisting asthma). etodolac extended-release tablets are

USA - engelsk - NLM (National Library of Medicine)

zydus lifesciences limited - paroxetine hydrochloride anhydrous (unii: 3i3t11ud2s) (paroxetine - unii:41vrh5220h, paroxetine - unii:41vrh5220h) - paroxetine 10 mg - paroxetine tablets, usp are indicated for the treatment of major depressive disorder. the efficacy of paroxetine tablets, usp in the treatment of a major depressive episode was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical pharmacology —clinical trials ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the effects of paroxetine tablets, usp in hospitalized depressed patients have not been adequately studied. the efficacy

Filippinerne - engelsk - FDA (Food And Drug Administration)

zydus philippines, inc.; distributor: zydus philippines, inc. - alendronate sodium - tablet - 70mg

Filippinerne - engelsk - FDA (Food And Drug Administration)

zydus philippines, inc.; distributor: zydus philippines, inc. - levetiracetam - film coated tablet - 500 mg

Filippinerne - engelsk - FDA (Food And Drug Administration)

zydus philippines, inc.; distributor: zydus philippines, inc. - levetiracetam - film coated tablet - 750 mg

Filippinerne - engelsk - FDA (Food And Drug Administration)

zydus philippines, inc.; distributor: zydus philippines, inc. - levetiracetam - film coated tablet - 1000 mg

Filippinerne - engelsk - FDA (Food And Drug Administration)

zydus philippines, inc.; distributor: zydus philippines, inc. - losartan (as potassium) - film coated tablet - 100 mg